HUP0101514A3 - Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine - Google Patents
Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamineInfo
- Publication number
- HUP0101514A3 HUP0101514A3 HU0101514A HUP0101514A HUP0101514A3 HU P0101514 A3 HUP0101514 A3 HU P0101514A3 HU 0101514 A HU0101514 A HU 0101514A HU P0101514 A HUP0101514 A HU P0101514A HU P0101514 A3 HUP0101514 A3 HU P0101514A3
- Authority
- HU
- Hungary
- Prior art keywords
- acetylglucosamine
- treatment
- composition
- inflammatory bowel
- bowel disease
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 title 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 title 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 title 1
- 210000001072 colon Anatomy 0.000 title 1
- 229950006780 n-acetylglucosamine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002234936A CA2234936C (en) | 1998-04-17 | 1998-04-17 | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
| PCT/CA1999/000218 WO1999053929A1 (en) | 1998-04-17 | 1999-03-12 | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101514A2 HUP0101514A2 (en) | 2001-11-28 |
| HUP0101514A3 true HUP0101514A3 (en) | 2003-07-28 |
Family
ID=4162337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101514A HUP0101514A3 (en) | 1998-04-17 | 1999-03-12 | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1071432A1 (en) |
| JP (1) | JP2002512195A (en) |
| CA (1) | CA2234936C (en) |
| CZ (1) | CZ20003846A3 (en) |
| HU (1) | HUP0101514A3 (en) |
| IL (1) | IL139072A0 (en) |
| NO (1) | NO20005223L (en) |
| PL (1) | PL343634A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008103345A2 (en) | 2007-02-19 | 2008-08-28 | Marine Polymer Technologies, Inc. | Hemostatic compositions and therapeutic regimens |
| KR101098581B1 (en) * | 2009-01-09 | 2011-12-26 | 서울대학교산학협력단 | Composition for Improving Inflammatory Disorder Using ABH Antigen |
| CN103108638B (en) | 2010-04-15 | 2016-11-09 | 海洋聚合物技术公司 | The antibacterial applications of poly-n-acetyl glucosamine amine nanofiber |
| WO2012142581A1 (en) | 2011-04-15 | 2012-10-18 | Marine Polymer Technologies, Inc. | Treatment of disease with poly-n-acety glucosamine nanofibers |
| US9539265B2 (en) | 2013-03-15 | 2017-01-10 | Aihol Corporation | Pharmaceutical formulation containing glycosaminoglycan |
| WO2014142938A1 (en) * | 2013-03-15 | 2014-09-18 | Aihol Corporation | Pharmaceutical formulation containing glycosaminoglycan |
| HUE049247T2 (en) * | 2014-11-26 | 2020-09-28 | Evonik Operations Gmbh | Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
| KR102104507B1 (en) * | 2019-08-23 | 2020-04-24 | 브릿지바이오테라퓨틱스(주) | Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same |
-
1998
- 1998-04-17 CA CA002234936A patent/CA2234936C/en not_active Expired - Fee Related
-
1999
- 1999-03-12 PL PL99343634A patent/PL343634A1/en unknown
- 1999-03-12 EP EP99907220A patent/EP1071432A1/en not_active Withdrawn
- 1999-03-12 CZ CZ20003846A patent/CZ20003846A3/en unknown
- 1999-03-12 IL IL13907299A patent/IL139072A0/en unknown
- 1999-03-12 HU HU0101514A patent/HUP0101514A3/en unknown
- 1999-03-12 JP JP2000544333A patent/JP2002512195A/en active Pending
-
2000
- 2000-10-17 NO NO20005223A patent/NO20005223L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL139072A0 (en) | 2001-11-25 |
| NO20005223D0 (en) | 2000-10-17 |
| PL343634A1 (en) | 2001-08-27 |
| NO20005223L (en) | 2000-11-20 |
| EP1071432A1 (en) | 2001-01-31 |
| CZ20003846A3 (en) | 2002-03-13 |
| HUP0101514A2 (en) | 2001-11-28 |
| JP2002512195A (en) | 2002-04-23 |
| CA2234936A1 (en) | 1999-10-17 |
| CA2234936C (en) | 2004-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL132145A (en) | Compositions for treating inflammatory bowel disease and uses thereof | |
| EP1581119A4 (en) | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease | |
| EP1240136A4 (en) | Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease | |
| HUP9900950A3 (en) | Use of nicotine derivatives for producing pharmaceutical compositions suitable for treating inflammatory bowel disease | |
| EP1578385A4 (en) | Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders | |
| IL142929A0 (en) | Local delivery of drugs to the colon for local treatment of colonic diseases | |
| EP1129217A4 (en) | Compositions and methods of disease diagnosis and therapy | |
| EP1119255A4 (en) | Novel compositions and methods for prevention and treatment of protozoal disease | |
| AU2027595A (en) | Pharmaceutical composition for treating inflammatory bowel diseases | |
| AU2001280982A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU6386499A (en) | Method and composition for treatment of inflammatory bowel disease | |
| AU2002246519A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| PL343634A1 (en) | Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine | |
| EP1085906A4 (en) | Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease | |
| IL147946A0 (en) | Treatment of inflammatory or malignant disease using dnazymes | |
| AU2001257406A1 (en) | Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 | |
| AU2001290518A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| AU1953701A (en) | Methods and compositions for treatment of inflammatory disease | |
| HUP9900309A3 (en) | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases | |
| EP1107778A4 (en) | Treatment of disease states | |
| AU4034800A (en) | Novel compositions and methods for prevention and treatment of protozoal disease | |
| HUP0000569A3 (en) | Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| GB9725346D0 (en) | Pharmaceutical composition for the treatment of inflammatory bowel disease | |
| AU2001294999A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
| GB9701041D0 (en) | Treatment of inflammatory bowel conditions |